New research to examine links between aluminium and Alzheimer's disease

NewsGuard 100/100 Score

New research is being carried out at Keele university to examine links between aluminium and Alzheimer's disease.

A study by scientists at Keele that was published in 2006 showed that aluminium could be removed from the body of individuals with Alzheimer's disease by asking them to drink a silicon-rich mineral water.
 
A new study is an extension of this, in which patient and carer are both drinking silicon-rich mineral water over a period of 13 weeks, during which their urinary excretion of aluminium, silicon and iron is monitored.  The scientists are now looking to recruit individuals into the study over the next few weeks.
 
Dr Christopher Exley, Reader in Bioinorganic Chemistry at Keele, said: "The primary objective is to confirm that regular drinking of a silicon-rich mineral water will help to remove aluminium from the body. Essentially the idea in the longer term is that if aluminium contributes to Alzheimer's disease, then removing it from the body could help people with Alzheimer's disease."
 
In the current study they are also monitoring the cognitive ability of patient and carer during the 13 week study period to see if either might benefit from drinking the silicon-rich mineral water.
 
Dr Exley added that it was important to stress that while dementia is a priority area for the present government, there are no effective treatments for Alzheimer's disease, even after 40 years of research. The Keele team is trying to test the hypothesis that aluminium might contribute towards Alzheimer's disease and if this is true then Alzheimer's disease patients will benefit from the simple task of drinking silicon-rich mineral water every day!

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings